Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Enlisting Viruses

September 24, 2015 7:30 am | by Anne Trafton, MIT News Office | News | Comments

In the hunt for new ways to kill harmful bacteria, scientists have turned to a natural predator: viruses that infect bacteria. Read more...


U.N. Ebola Response Now Planned to Continue Into 2016

September 24, 2015 7:00 am | by Krista Larson, Associated Press | News | Comments

The United Nations is now planning for its Ebola response to last into mid-2016. Read more...


Seeking a Better Way to Design Drugs

September 23, 2015 12:51 pm | by Worcester Polytechnic Institute | News | Comments

The National Institutes of Health (NIH) has awarded $346,000 to Worcester Polytechnic Institute (WPI) for a three-year research project to advance development of a chemical process that could significantly improve the ability to design new pharmaceuticals and streamline the manufacturing of existing drugs. Read more...


Amgen, Allergan: Positive Top-line Results From Phase 3 Study of Biosimilar Candidate

September 23, 2015 12:47 pm | News | Comments

Amgen and Allergan plc. today announced a Phase 3 study of biosimilar candidate ABP 215 met its primary and secondary endpoints. The study evaluated the efficacy and safety of ABP 215 compared with Avastin (bevacizumab) in adult patients with advanced non-squamous non-small cell lung cancer (NSCLC). Read more...


New Cancer Genes Identified, Opening Door to Targeted Treatments

September 23, 2015 12:42 pm | by University of Virginia | News | Comments

In a discovery that could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers at the University of Virginia School of Medicine have identified two new cancer-causing gene mutations – mutations that may be particularly susceptible to cancer-fighting drugs already approved by the federal Food and Drug Administration.  Read more...


Scientists Awarded $6 Million to Develop Alternative HIV/AIDS Vaccine

September 23, 2015 12:36 pm | by The Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded up to nearly $6 million from the Bill & Melinda Gates Foundation to develop a revolutionary HIV/AIDS alternative vaccine that has demonstrated great potential in animal models. Read more...


Clinton Plan to Reduce Drug Costs Gets Shrugs From Industry

September 23, 2015 12:32 pm | by Matthew Perrone, AP Health Writer | News | Comments

Hillary Rodham Clinton's plan to rein in prescription drug prices by reshaping how drugmakers do business is being met by skepticism within the industry. Read more...


Daraprim Price Will Be Lowered, Turing CEO Shkreli Says

September 23, 2015 11:08 am | by Stephanie Guzowski, Editor | News | Comments

After significantly hiking the price of antiparasitic drug Daraprim (pyrimethamine), from $13.50 per pill to $750 — and vehemently defending his company’s right to do so — Turing Pharmaceutical’s CEO Martin Shkreli backed down a bit late Tuesday. Shkreli told TV networks that his company has agreed to lower the price of the drug, Daraprim — but he didn’t specify what the new price would be. Read more...


Scientists Create Immunity to Deadly Parasite by Manipulating Host's Genes

September 23, 2015 8:15 am | by University of Virginia | News | Comments

There are two common approaches to protecting humans from infectious disease. Read more...


FDA Approves Taiho Oncology's MCRC Drug

September 23, 2015 8:00 am | News | Comments

Lonsurf is intended for the treatment of patients with a form metastatic colorectal cancer (mCRC) that is resistant to other forms of treatment. Read more...


Global HIV Therapeutics Market Value Will Crawl to Almost $15.3B by 2023

September 23, 2015 7:45 am | by Moritz Hermann, Ph.D., Analyst, GlobalData | News | Comments

The market growth will mainly be driven by the introduction of novel drugs, such as STRs with improved tolerability, a reduced pill burden or increased efficacy, and an increasing number of people living with HIV who are treated with antiretroviral therapy (ART). Read more...


Bausch + Lomb, Nicox Announce FDA Acceptance of NDA for Vesneo

September 23, 2015 7:30 am | News | Comments

Vesneo was licensed by Nicox to Bausch + Lomb. Read more...


Increased Chances for Early Detection of Alzheimer's Disease

September 23, 2015 7:15 am | by Lund University | News | Comments

A method for detecting early signs of Alzheimer’s disease using amyloid PET imaging works as well as the previously used cerebrospinal fluid sample method. Read more...


Pfizer says it Could be Leader in Cancer with Many New Drugs

September 23, 2015 7:00 am | by Linda A. Johnson, AP Business Writer | News | Comments

Drug giant Pfizer is starting 20 clinical trials this year and more soon after on treatments to conquer cancer as it also seeks to gain leadership in one of the hottest, and most lucrative, areas of medicine. Read more...


Scientists Identify DNA Alterations as Among Earliest to Occur in Lung Cancer Development

September 22, 2015 12:51 pm | by Johns Hopkins University | News | Comments

Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest “premalignant” genetic changes that mark the potential onset of the most common and deadliest form of disease. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.